secwatch.observer — SEC 8-K summary
======================================

Issuer:     GUIDED THERAPEUTICS INC (GTHP)
CIK:        0000924515
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001477932-23-001383
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Guided Therapeutics CEO Gene Cartwright retires; Mark Faupel appointed as successor
--------------------------------------------------------------------------------

- Gene Cartwright retired as President, CEO, and Board member effective March 3, 2023; no disagreement cited.
- Board appointed COO Dr. Mark Faupel (Ph.D., 67) as President and CEO effective March 6, 2023; he was CEO from 2007-2013.
- Alan Grujic appointed to Board effective March 8, 2023; brings finance and hedge fund experience.
- Faupel's compensation as CEO to be determined later by compensation committee.
- Grujic is not appointed to any Board committees; no related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/0001477932-23-001383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/924515/000147793223001383/gthp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-001383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer